| 101/401 | US=9 / Urologia Madan RA, Gulley JL, Celestin J, Arlen PM, Schlom J. Cancer immunology, immunotherapeutics, and vaccine approaches. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 305-19. ISBN 978-1-60327-831-7. CANCER DE IMUNOLOGIA; IMUNOTERAPIA; VACINA DO CANCER; CANCER DE PROSTATA |
| 102/401 | US=9 / Urologia Higano CS. Sipuleucel-T: autologous cellular immunotherapy for metastatic castration-resistant prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 321-27. ISBN 978-1-60327-831-7. SIPULEUCEL-T; IMUNOTERAPIA CELULAR AUTOLOGA; CANCER DE PROSTATA; METASTATICO RESISTENTE A CASTRACAO; HORMONIO REFRATARIO; PROVENCE; IMUNOTERAPIA CELULAR AUTOLOGA; RESISTENTE A CASTRACAO; APC8015 |
| 103/401 | US=9 / Urologia Patel LR, Simons JW. GM-CSF gene-transduced prostate cancer vaccines: GVAX. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 329-42. ISBN 978-1-60327-831-7. |
| 104/401 | US=9 / Urologia Chan JM, Richman EL. Diet and prostate cancer incidence, recurrence, and progression risk. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 363-73. ISBN 978-1-60327-831-7. |
| 105/401 | US=9 / Urologia Lucia MS, Lambert JR, Platz EA, Marzo AM. Inflammation as a target in prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 375-86. ISBN 978-1-60327-831-7. INFLAMACAO; CANCER DE PROSTATA; CARCINOGENESE; QUIMIOPREVENCAO; QUIMIOTERAPIA; CITOCINAS; INFLAMACAO; ESTRESSE OXIDATIVO |
| 106/401 | US=9 / Urologia Alva AS, Bradley DA, Hussain M. Challenges for the development of new agents in prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 389-97. ISBN 978-1-60327-831-7. CANCER DE PROSTATA; NOVOS AGENTES DIRECIONADOS; DESAFIOS; DESENVOLVIMENTO DE MEDICAMENTOS |
| 107/401 | US=9 / Urologia Ning YM, Dagher RN, Pazdur R. FDA approval of prostate cancer treatments. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 399-405. ISBN 978-1-60327-831-7. FDA DOS TRATAMENTOS DO CANCER DE PROSTATA; APROVACAO DE MEDICAMENTOS; DESENVOLVIMENTO DE MEDICAMENTOS; ENDPOINTS; FDA; ANALISE POST-HOC; CANCER DE PROSTATA; ANALISE DE SUBGRUPO; PARAMETROS DE SUBSTITUICAO; SOBREVIVENCIA |
| 108/401 | US=9 / Urologia Gross M, Nepomuceno EM, Agus DB. Applications of proteomics in prostate cancer. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 407-17. ISBN 978-1-60327-831-7. PROTEOMICA; CANCER DE PROSTATA; ESPECTROMETRIA DE MASSA; BIOMARCADOR; ANTIGENO PROSTATICO ESPECIFICO; IMUNO-HISTOQUIMICA |
| 109/401 | US=26-A / Radioterapia Lee AK, Pollack A. The prostate. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 676-729. ISBN 978-0-323-04971-9. PROSTATA; CANCER DE PROSTATA; RADIOTERAPIA; TECNICAS RADIOTERAPICAS; BRAQUITERAPIA; PROSTATECTOMIA; CRIOTERAPIA |
| 110/401 | US=3-I / Patologia Epstein JI. The lower urinary tract and male genital system. In: Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran pathologic basis of disease. 8ª ed. Philadelphia: Saunders Elsevier, 2010. p. 971-1004. ISBN 978-0-4160-3121-5. TRATO URINARIO INFERIOR; SISTEMA GENITAL MASCULINO; URETER. ANOMALIAS CONGENITAS; URETRITE; BEXIGA. ANOMALIAS CONGENITAS; CANCER DE BEXIGA; OBSTRUCAO DA BEXIGA; URETRA; CANCER DE URETRA; PENIS. ANOMALIAS CONGENITAS; CANCER DE PENIS; TESTICULO; EPIDIDIMO; CRIPTOCHIDISMO; ATROFIA; ORCHITE GRANULOMATOSA; TORCAO TESTICULAR; CANCER DE TESTICULOS; PROSTATA; PROSTATITE; HIPERPLASIA BENIGNA DA PROSTATA; CANCER DE PROSTATA; ADENOCARCINOMA DA PROSTATA |
| 111/401 | US=6 / Ortopedia Peyruchaud O, Karin NJ. Lysophosphatidic acid: role in bone and bone cancer. In: Bronner F, Farac-Carson MC. Bone and cancer. New York: Springer-Verlag, 2009. p. 73-88. (Topics in bone biology) ISBN 978-1-84882-018-0. ACIDO LISOFOSFATIDICO (LPA); CANCER OSSEO; ATIVIDADES BIOLOGICAS DA LPA; RECEPTORES DA LPA; EFEITOS DA LPA NAS CELULAS ESQUELETICAS; FUNCOES REGULADORAS DA LPA; CANCER METASTATICO DO OSSO; CANCER DE TIREOIDE; CANCER DE PROSTATA; CANCER DE MAMA |
| 112/401 | US=6 / Ortopedia Chung LWK, Zhau HE, Petros JA, Farach-Carson MC. Prostate cancer bone colonization: osteomimicry in the bone niche. In: Bronner F, Farac-Carson MC. Bone and cancer. New York: Springer-Verlag, 2009. p. 157-66. (Topics in bone biology) ISBN 978-1-84882-018-0. CANCER OSSEO; CANCER DE PROSTATA; OSTEOMIMICRY; NICHO OSSEO; ALTERACOES FENOTIPICAS; RANKL; OSTEOCLASTOGENESE |
| 113/401 | US=6 / Ortopedia Taxel P, Mirza FS. Hormonal therapies in breast and prostate cancer: effects on bone and the role of bisphosphonates. In: Bronner F, Farac-Carson MC. Bone and cancer. New York: Springer-Verlag, 2009. p. 205-18. (Topics in bone biology) ISBN 978-1-84882-018-0. TERAPIAS HORMONAIS; CANCER DE MAMA; CANCER DE PROSTATA; BISFOSFONATOS; INIBIDORES DA AROMATASE; PERDA OSSEA. PREVENCAO; PERDA OSSEA. TRATAMENTO; OSTEOPOROSE |
| 114/401 | US=6 / Ortopedia Grubbs SS, Schneider CJ. Therapeutic approaches to metastatic bone cancer II: targeted and non-targeted systemic agents. In: Bronner F, Farac-Carson MC. Bone and cancer. New York: Springer-Verlag, 2009. p. 219-27. (Topics in bone biology) ISBN 978-1-84882-018-0. CANCER METASTATICO DO OSSO II; AGENTES SISTEMICOS ALVO; AGENTES SISTEMICOS NAO-ALVO; CARCINOMA DE CELULAS RENAIS; CANCER DE TIREOIDE; CANCER DE PROSTATA; CANCER DE MAMA; CANCER DE PULMAO; RADIOFARMACOS |
| 115/401 | US=9 / Urologia Hammerich KH, Ayala GE, Wheeler TM. Anatomy of the prostate gland and surgical pathology of prostate cancer. In: Hricak H, Scardino PT. Prostate cancer. New York: Cambridge University Press, 2009. p. 1-14. (Contemporary issues in cancer imaging) ISBN 978-0-521-88704-5. GLANDULA DA PROSTATA. ANATOMIA; PATOLOGIA CIRURGICA; CANCER DE PROSTATA; GRADUACAO DE GLEASON; ADENOCARCINOMA DE PROSTATA |
| 116/401 | US=9 / Urologia Garzotto M. The natural and treated history of prostate cancer. In: Hricak H, Scardino PT. Prostate cancer. New York: Cambridge University Press, 2009. p. 15-28. (Contemporary issues in cancer imaging) ISBN 978-0-521-88704-5. CANCER DE PROSTATA; ADENOCARCINOMA DE PROSTATA; ANTIGENO PROSTATICO ESPECIFICO (PSA); ENSAIOS CLINICOS RANDOMIZADOS |
| 117/401 | US=9 / Urologia Hricak H, Scardino PT. Current clinical issues in prostate cancer that can be addressed by imaging. In: ___. Prostate cancer. New York: Cambridge University Press, 2009. p. 29-42. (Contemporary issues in cancer imaging) ISBN 978-0-521-88704-5. CANCER DE PROSTATA; IMAGEM; ANTIGENO PROSTATICO ESPECIFICO (PSA); DETECCAO DE RECORRENCIA LOCAL |
| 118/401 | US=9 / Urologia Masterson TA, Eastham JA. Surgical treatment of prostate cancer. In: Hricak H, Scardino PT. Prostate cancer. New York: Cambridge University Press, 2009. p. 43-57. (Contemporary issues in cancer imaging) ISBN 978-0-521-88704-5. CANCER DE PROSTATA; TRATAMENTO CIRURGICO; AVALIACAO PRE-OPERATORIA |
| 119/401 | US=9 / Urologia Kollmeier MA, Zelefsky MJ. Radiation therapy. In: Hricak H, Scardino PT. Prostate cancer. New York: Cambridge University Press, 2009. p. 58-92. (Contemporary issues in cancer imaging) ISBN 978-0-521-88704-5. CANCER DE PROSTATA; IMAGEM; RADIOTERAPIA; ESTRATIFICACAO DE RISCO; RADIOTERAPIA POR FEIXE EXTERNO (EBRT); RADIOTERAPIA DE INTENSIDADE. MODULADA (IMRT); RADIOTERAPIA GUIADA POR IMAGEM; HIPOFRACIONAMENTO NO CANCER DE PROSTATA; BRAQUITERAPIA; SUPRESSAO ANDROGENICA |
| 120/401 | US=9 / Urologia Schwartz LH, Morris MJ. Systemic therapy. In: Hricak H, Scardino PT. Prostate cancer. New York: Cambridge University Press, 2009. p. 93-101. (Contemporary issues in cancer imaging) ISBN 978-0-521-88704-5. CANCER DE PROSTATA; TERAPIA SISTEMICA; TERAPIA HORMONAL; TERAPIA DE PRIVACAO DO ANDROGENO; QUIMIOTERAPIA; TRATAMENTO PALIATIVO |